January 2015

New Product - Definity

Definity (perflutren) produces perflutren lipid microspheres after activation. When used in conjunction with diagnostic ultrasound, Definity provides opacification of cardiac chambers, improvement in delineation of endocardial borders and assessment of regional myocardial wall motion. Definity provides contrast enhancement in ultrasound studies of the liver and kidney and enhancement of Doppler ultrasound assessment of the vasculature of the liver and kidney. Definity is available as a pack containing 4 clear glass vials containing perflutren 6.52 mg/mL.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia┬áPty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629